Stock

Elizabeth Holmes, disgraced Theranos founder, will report to prison to begin 11-year sentence

Elizabeth Holmes, the founder of blood lab Theranos who became the face of Silicon Valley duplicity after her company collapsed amid fraud claims, is scheduled to report to prison Tuesday to begin her sentence of more than 11 years.

Holmes was found guilty in January 2022 of four counts of wire fraud. Her conviction was the culmination of a saga that began in 2003, when she dropped out of Stanford University at age 19 to start a company whose technology she hoped could diagnose a multitude of conditions with just a pinprick of blood. Over the next decade, Holmes built Theranos into a darling of Silicon Valley that at one point was valued at more than $9 billion.

Theranos attracted investment from high-profile moguls, including Rupert Murdoch, the Walton family (heirs to the Walmart fortune), and former Education Secretary Betsy DeVos. Theranos’ board of directors would grow to include former secretaries of state George Shultz and Henry Kissinger; two former U.S. senators; and former Defense Secretary James Mattis.

But Theranos’ claims about its capabilities began to unravel amid reports, led by then-Wall Street Journal journalist John Carreyrou, that the company’s technology did not appear to work as claimed and that it could deliver faulty results.

By March 2018, the Securities and Exchange Commission had charged Holmes, as well as Theranos Chief Operating Officer Ramesh ‘Sunny’ Balwani — who was also romantically linked to Holmes — with securities fraud. At that point, Theranos stripped Holmes of her stake in and control of the company. In June 2018, Holmes and Balwani were indicted on federal fraud charges. By that fall, Theranos had announced it would dissolve.

Holmes’ and Balwani’s trials would be delayed by the pandemic until fall 2021. Holmes’ defense largely consisted of claims that she was under the control of Balwani, an argument Balwani subsequently denied. Holmes also argued she had not sought to mislead investors.

The jury rejected most of Holmes’ arguments and delivered its guilty verdict. In fall 2022, Holmes and Balwani, who had also been found guilty, were sentenced. Experts say Balwani earned a harsher sentence — nearly 13 years in prison — because of his experience running other businesses.

Along the way, various motions for appeals and delays were largely denied. Holmes, now 39, recently gave birth to her second child.

She will report to a minimum-security facility in Texas. Balwani, 57, began serving his sentence in April in California.

In a recent New York Times profile, Holmes indicated she still harbored ambitions to build in the medical technology industry.

“I still dream about being able to contribute in that space,” Holmes said. “I still feel the same calling to it as I always did and I still think the need is there.”

This post appeared first on NBC NEWS

You May Also Like

Economy

Gmatrixs ICO: Empowering Blockchain Game Development with New Solutions   The game industry has long recognized the importance of a robust game Publishing Platform,...

Editor's Pick

The Internet of Things (IoT) is becoming increasingly ubiquitous. Yet, with more devices connected, the opportunities for businesses to innovate and improve their operations...

Economy

Morpheus ICO: Streamlining Global Logistics with MRP Token Morpheus.Network, a pioneering blockchain-based platform, has set its sights on revolutionizing the logistics industry. The company...

Latest News

North Carolina Republicans say they are closing in on a state budget deal, with top House and Senate leaders acknowledging on Monday an income...

Disclaimer: Greycardinalbussiness.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Greycardinalbussiness.com

Exit mobile version